The Signal Transduction and Targeted Therapy is a reputed indexed journal. The Journal is published by Springer Nature.
- Publisher: Springer Nature
- ISSN: 20593635, 20959907
- Journal Impact Factor: 81.2
- SJR: 17.740
- Journal Quartile: Q1
- Publication Language: ENG
- Indexing: Embase, Web of Science, DOAJ, PubMed, UGC
- Open-Access: Yes
- Country of Publication: United Kingdom
- Review Process: Anonymous peer review
- H-Index: 224
- Time Between Submission and Publication (in weeks): 5
- Article Publication Charges: Yes
- Article Publication Charges: 3090 GBP; 4170 USD; 3390 EUR
- Waiver Policy: Yes
- Publication Area: Cancer Research (Q1); Genetics (Q1)
Source: https://www.nature.com/sigtrans/